Literature DB >> 6540128

A new concept for the effector mechanism of intravenous immunoglobulin in hemocytopenias.

C Mueller-Eckhardt, A Salama, V Kiefel, E Küenzlen, C Förster.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6540128     DOI: 10.1007/bf00319962

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


× No keyword cloud information.
  12 in total

1.  125 I-anti-immunoglobulin test: a new tool for the detection of drug-allergic platelet antibodies.

Authors:  C Mueller-Eckhardt; G Schulz; C Dienst; I Mahn; B Mayser
Journal:  Vox Sang       Date:  1978       Impact factor: 2.144

2.  [On the question of detection of antithrombocytic autoantibodies. Comparative studies of thrombocytopenic and nonthrombocytopenic patients with the antiglobulin consumption test and the fluorescence antiglobulin test].

Authors:  C Mueller-Eckhardt; H Boehm
Journal:  Klin Wochenschr       Date:  1968-09-15

3.  Effect of intravenous immunoglobulin in immune thrombocytopenia.

Authors:  A Salama; C Mueller-Eckhardt; V Kiefel
Journal:  Lancet       Date:  1983-07-23       Impact factor: 79.321

4.  Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

Authors:  J Fehr; V Hofmann; U Kappeler
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

Review 5.  Chronic idiopathic thrombocytopenic purpura.

Authors:  R McMillan
Journal:  N Engl J Med       Date:  1981-05-07       Impact factor: 91.245

6.  The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders.

Authors:  C Mueller-Eckhardt; W Kayser; K Mersch-Baumert; G Mueller-Eckhardt; M Breidenbach; H G Kugel; M Graubner
Journal:  Br J Haematol       Date:  1980-09       Impact factor: 6.998

7.  Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content.

Authors:  J Römer; J J Morgenthaler; R Scherz; F Skvaril
Journal:  Vox Sang       Date:  1982-02       Impact factor: 2.144

8.  Platelet associated IgG, platelet survival, and platelet sequestration in thrombocytopenic states.

Authors:  C Mueller-Eckhardt; G Mueller-Eckhardt; W Kayser; R M Voss; J Wegner; E Küenzlen
Journal:  Br J Haematol       Date:  1982-09       Impact factor: 6.998

9.  Influence of the amount of platelet-bound IgG on platelet survival and site of sequestration in autoimmune thrombocytopenia.

Authors:  L M Kernoff; K C Blake; D Shackleton
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

10.  Platelet-associated complement C3 in thrombocytopenic states.

Authors:  W Kayser; C Mueller-Eckhardt; S Bhakdi; K Ebert
Journal:  Br J Haematol       Date:  1983-07       Impact factor: 6.998

View more
  4 in total

1.  Red cell sequestration during high dose intravenous immunoglobulin in idiopathic thrombocytopenic purpura.

Authors:  M G Macey; E A Macintyre; A C Newland
Journal:  Blut       Date:  1986-08

2.  Are aggregates of IgG the effective part of high-dose immunoglobulin therapy in adult idiopathic thrombocytopenic purpura (ITP)?

Authors:  W Augener; B Friedmann; G Brittinger
Journal:  Blut       Date:  1985-04

3.  Specific and nonspecific mechanisms of action of immunoglobulin G in therapy of idiopathic thrombocytopenic purpura (ITP).

Authors:  T W Jungi; P Imbach; S Barandun
Journal:  Blut       Date:  1984-06

Review 4.  IVIG in the treatment of children with acute and chronic idiopathic thrombocytopenic purpura and the autoimmune cytopenias.

Authors:  D J Nugent
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.